« Cardiopulmonary Corp: FDA Final Rule - Active Patient Monitoring Or | Main | FDA: U.S. Marshals seize food products at Tennessee company U.S. »

FDA approves Benlysta to treat lupus The U.S. Food and


FDA approves Benlysta to treat lupus
The U.S. Food and Drug Administration today approved Benlysta (belimumab) to treat patients with active, autoantibody-positive lupus (systemic lupus erythematosus) who are receiving standard therapy, including corticosteroids, antimalarials, immunosuppressives, and nonsteroidal anti-inflammatory drugs.
 

©2006 FDA-News.com. All rights reserved.